Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NCKAP5 antisense RNA 1 (NCKAP5-AS1)
- Target
- NCKAP5-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA family
01
Overview
NCKAP5 antisense RNA 1 (NCKAP5-AS1) is a long non-coding RNA that is transcribed from the DNA strand opposite to the NCKAP5 coding region. Like other antisense lncRNAs, it is involved in the regulation of its sense gene and possibly other genes through mechanisms such as chromatin remodeling, transcriptional interference, and modulation of RNA stability. Antisense lncRNAs can act as oncogenes or tumor suppressors by influencing cell proliferation, migration, invasion, and therapy resistance, mainly in the context of cancer. NCKAP5-AS1 is not a protein or receptor, and there are no established therapeutic agents or biomarkers directly targeting it based on current evidence[2][4].
- Other names
- NCKAP5-AS1
02
Mechanism of action
Not directly drug-targeted; antisense oligonucleotides can degrade or modulate lncRNAs via RNase H-mediated cleavage or steric blocking
03
Biological functions
Regulation of gene expression (cis and trans regulation at transcriptional and post-transcriptional levels)Potential regulation of nearby gene (NCKAP5) expressionInvolvement in chromatin modification, transcriptional interference, and possibly RNA stability
04
Disease associations
Cancer (lncRNA and antisense lncRNAs are often implicated in cancer biology, including acting as oncogenes or tumor suppressors)Other: Specific disease roles for NCKAP5-AS1 itself are incompletely characterized, but by analogy to other antisense lncRNAs, roles in tumorigenesis or tumor progression are likely
Beyond the preview
Go deeper on NCKAP5 antisense RNA 1 (NCKAP5-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NCKAP5 antisense RNA 1 (NCKAP5-AS1).